دوره 12، شماره 4 - ( 10-1403 )
جلد 12 شماره 4 صفحات 136-129 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ebrahimi Shah-abadi M, Heydari M, Najmaddini M, Soltani E. Outcomes of Hemostatic Management in Hemophilia Patients without Inhibitors Undergoing Invasive or Surgical Procedures: A Systemic Review and Meta-analysis. J Surg Trauma 2024; 12 (4) :129-136
URL: http://jsurgery.bums.ac.ir/article-1-386-fa.html
URL: http://jsurgery.bums.ac.ir/article-1-386-fa.html
Outcomes of Hemostatic Management in Hemophilia Patients without Inhibitors Undergoing Invasive or Surgical Procedures: A Systemic Review and Meta-analysis. نشریه جراحی و تروما. 1403; 12 (4) :129-136
چکیده: (500 مشاهده)
Introduction: There are numerous questions surrounding the use, duration of administration, and dosage of clotting factor concentrates (CFC). This issue has been so far very controversial and challenging. Given the critical oitre1importance of the subject, the present study aimed to assess the outcomes of perioperative hemostatic management in hemophilia patients without inhibitors undergoing invasive or surgical procedures.
Methods: All articles published in international databases, such as PubMed, Scopus, Science Direct, and Embase, until May 2022 were included. Data analysis was performed using STATA software (version 16).
Results: The search in databases yielded 1,218 articles and the full text of 192 articles was reviewed. Finally, nine articles that met the inclusion criteria entered the analysis. Mean differences of bleeding rate between high-dose prophylaxis and episodic groups was -53.40 (MD; 95 CI (-53.72, -53.08); P=0.01). The mean differences of joint bleeding rate between intermediate dose prophylaxis and episodic groups was -12.79 (MD; 95 CI (-12.85, -12.74); P=0.01).
Conclusion: Based on the present meta-analysis, it was revealed that in patients with hemophilia A, the use of prophylaxis has better results in terms of annualized bleeding rate and annualized joint bleeding rate than episodic treatment.
Methods: All articles published in international databases, such as PubMed, Scopus, Science Direct, and Embase, until May 2022 were included. Data analysis was performed using STATA software (version 16).
Results: The search in databases yielded 1,218 articles and the full text of 192 articles was reviewed. Finally, nine articles that met the inclusion criteria entered the analysis. Mean differences of bleeding rate between high-dose prophylaxis and episodic groups was -53.40 (MD; 95 CI (-53.72, -53.08); P=0.01). The mean differences of joint bleeding rate between intermediate dose prophylaxis and episodic groups was -12.79 (MD; 95 CI (-12.85, -12.74); P=0.01).
Conclusion: Based on the present meta-analysis, it was revealed that in patients with hemophilia A, the use of prophylaxis has better results in terms of annualized bleeding rate and annualized joint bleeding rate than episodic treatment.
نوع مطالعه: متاآنالیز |
موضوع مقاله:
جراحی عمومی
دریافت: 1402/4/2 | پذیرش: 1403/9/25 | انتشار الکترونیک پیش از انتشار نهایی: 1403/10/1 | انتشار: 1403/10/10
دریافت: 1402/4/2 | پذیرش: 1403/9/25 | انتشار الکترونیک پیش از انتشار نهایی: 1403/10/1 | انتشار: 1403/10/10
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
